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Abstract
Background: Little research to date has focused on lower urinary tract symptom (LUTS) prevention and
bladder health promotion in women. To address this gap, the Prevention of LUTS Research Consortium
developed the following working bladder health definition: ‘‘A complete state of physical, mental, and social
well-being related to bladder function [that] permits daily activities [and] allows optimal well-being.’’ To begin
to inform and quantify this definition, we used data from the Boston Area Community Health Survey, drawing
upon its rare collection of information on LUTS and LUTS-specific interference with activities.
Methods: At baseline, participants reported their frequency of 15 LUTS and interference with 7 activities.
Prevalence ratios (PRs) were calculated by generalized linear models with robust variance estimation, adjusting
for LUTS risk factors and individual LUTS.
Results: Of the 3169 eligible participants, 17.5% reported no LUTS or interference, whereas the remaining
82.5% reported some frequency of LUTS/interference: 15.1% rarely; 21.7% a few times; 22.6% fairly of-
ten/usually; and 22.9% almost always. LUTS independently associated with interference were urgency in-
continence, any incontinence, urgency, nocturia, perceived frequency, and urinating again after <2 hours
(PRs = 1.2–1.5, all p < 0.05).
Conclusions: Our findings suggest that bladder health exists on a continuum, with approximately one in five
women considered to have optimal bladder health (no LUTS/interference), the majority to have intermediate
health (LUTS/interference rarely to usually), and a further one in five to have worse or poor health (LUTS/
interference almost always). These findings underscore the need for LUTS prevention and bladder health
promotion.
Keywords: prevention, incontinence, public health, health promotion
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Introduction
Lower urinary tract symptoms (LUTS) include stor-age symptoms, such as urgency and frequency; voiding
symptoms, such as weak stream; incontinence symptoms;
and lower urinary tract pain.1 LUTS are common,2–4 cost-
ly,5–7 and adversely impact many women’s lives.Womenwith
LUTS have decreased physical, mental, and sexual health;
decreased work productivity3,8,9; and increased risks of falls,
fractures,10 social isolation, and shame.11 Despite their high
prevalence and societal costs, most research on LUTS in wo-
men to date has focused on prevalence and treatment, whereas
considerably less has focused on risk factors and prevention.12
Even less has incorporated well-being and examined promo-
tion and maintenance of bladder health.
Health is defined by the World Health Organization as ‘‘a
state of complete physical, mental, and social well-being and
not merely the absence of disease or infirmity.’’13 In the Pre-
vention of Lower Urinary Tract Symptoms (PLUS) Research
Consortium,12 we adapted this definition to create the following
working bladder health definition: ‘‘A complete state of phys-
ical, mental, and social well-being related to bladder function,
and not merely the absence of LUTS. Healthy bladder function
permits daily activities, adapts to short-term physical and en-
vironmental stressors, and allows optimal well-being (e.g., tra-
vel, exercise, social, occupational, or other activities).’’14
In addition to overall bladder health, we also applied this
concept to the three main functions of the bladder (‘‘storage,’’
‘‘emptying,’’ and ‘‘bioregulatory’’) and described unhealthy
characteristics of each. These included LUTS, such as urinary
incontinence, urgency, and pain with bladder filling for un-
healthy storage; weak stream, incomplete emptying, and pain
with urination for unhealthy emptying; and urinary tract in-
fections (UTIs) for unhealthy bioregulatory function.14
Although the proposed working bladder health definition
represents a major step forward in conceptualizing bladder
health, we do not yet have data to quantify and further refine
this concept. Therefore, we took advantage of existing data
from the Boston Area Community Health (BACH) survey,
drawing upon its extensive collection of information on
LUTS and bladder dysfunction, as well as its rare collection
of information on LUTS-specific interference with activities
(e.g., travel, exercise, and social activities) in women unse-
lected for LUTS.
Methods
Study population and design
The BACH survey is a population-based, longitudinal
study of community-dwelling residents from Boston, Mas-
sachusetts (n = 5506). Participants were recruited from 2002
to 2005 using a two-stage cluster design, with stratification by
sex, race/ethnicity (equally distributed across Black, His-
panic, and White), and age (30–39, 40–49, 50–59, and 60–79
years). At baseline, participants completed an in-home in-
terview and self-administered questionnaire, and had their
height, weight, and waist circumference measured.15 Of the
eligible Boston residents who were successfully contacted,
63.4% completed the baseline assessment. The BACH survey
was approved by the New England Research Institutes In-
stitutional Review Board and all participants provided writ-
ten informed consent.
For the present analysis, we used baseline data for female
participants only. Participants were excluded if they did not
provide complete data on LUTS (all analyses), interference
(all analyses), and covariates (association analyses only).
Assessment of LUTS and bladder dysfunction
Several measures of storage, emptying, and bioregulatory
dysfunction were assessed at baseline. These included LUTS,
such as urgency incontinence, nocturia, and pain with bladder
filling, to capture unhealthy storage; hesitancy, incomplete
emptying, and pain with urination to capture unhealthy emp-
tying; and UTIs to capture unhealthy bioregulatory function.
As most of these measures were symptoms, we refer to them
hereafter as ‘‘LUTS’’ for simplicity. LUTS were assessed
by validated questionnaires (American Urological Asso-
ciation Symptom Index,16 Sandvik Incontinence Severity
Scale,17 and Interstitial Cystitis Symptom Index18) and
items written specifically for BACH. Incontinence manage-
ment, such as pad use, was also queried for those who en-
dorsed incontinence.
As several items used similar wording and/or captured
similar LUTS, we collapsed the 24 LUTS items assessed into
15 combined LUTS. For each combined LUTS, we used a
criterion of £20% disagreement across responses to combine
items (Appendix Table A1), and the maximum response from
any of the contributing items to capture LUTS frequency.
Assessment of interference
We assessed interference using the benign prostatic hy-
perplasia (BPH)-specific interference with activities domain
of the Epstein Quality-of-Life Questionnaire for BPH.19 This
validated scale queries the frequency of interference from
urinary problems in the past month with five daytime activ-
ities (drinking fluids before travel; driving for 2 hours without
stopping; going to places that may not have a toilet; playing
sports outdoors such as golf; and going to movies, shows, and
church), and two nighttime activities (drinking fluids before
bed and getting enough sleep at night). The Epstein scale was
modified for BACH to refer to urinary ‘‘problems’’ as ‘‘expe-
riences’’ and to include interference due to pain or discomfort
in the pubic area to increase its relevance for interstitial cys-
titis/bladder pain syndrome.20
Although the Epstein scale was designed for men with BPH,
we used it to measure interference in our female population
for several reasons: (1) it was the only scale that assessed
LUTS-specific interference in all women (i.e., unselected for
LUTS) at baseline in BACH; (2) it has been used extensively
in analyses of female participants in BACH3,20–22; and (3) it
captures several activities referenced in our working bladder
health definition (i.e., travel, exercise, and social activities).
Assessment of covariates
Additional variables considered in the analysis were as-
sessed during the baseline interview or measured during the
baseline assessment. Self-reported variables included age;
race; menopausal status; parity; cigarette smoking status;
alcohol intake; health-related limitations in activities (mod-
erate activities and climbing several flights of stairs); medical
diagnoses of high blood pressure, diabetes types I and II,
cardiovascular disease, and arthritis; and current depressive
2 SUTCLIFFE ET AL.
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symptoms (measured by a revised version of the Center for
Epidemiologic Studies of Depression Scale23). Measured
variables included body mass index (BMI) and waist cir-
cumference.
Statistical analyses
To account for the BACH sampling design, we weighted
all observations inversely proportional to their probability of
selection, with further poststratification to the Boston popu-
lation using the 2000 U.S. Census.15 As the distribution of
bladder health has not yet been described, we used several
approaches to begin to quantify this distribution. Our primary
approach was a crosstabulation of the maximum frequency of
LUTS (out of 12 LUTS, using any incontinence in the past
year rather than individual types of incontinence in the past
week) and interference. Women with previous or current
bladder conditions (i.e., use of current LUTS medications,
previous incontinence or bladder surgery, chronic indwelling
catheterization, and bladder cancer) were included in the
highest LUTS/interference category to acknowledge their
poorer bladder health and to avoid misclassifying them as
having better bladder health because of the influence of
treatment on their current LUTS and interference frequency.
Additional exploratory approaches used to describe the
distribution of bladder health were: (1) a crosstabulation of
the number of reported LUTS (out of 12) and activities as-
sociated with interference; (2) a scatterplot of interference
and LUTS scores; and (3) a histogram of a combined inter-
ference and LUTS score. We calculated the interference
score by summing the frequency of interference (0–4) with
each of the seven activities (range: 0–28).19 The LUTS score
was calculated by summing the frequency (0–5, except for
any incontinence: 0–4) of the above-described 12 LUTS
(range: 0–59) and then multiplying this sum by 28/59 to
obtain a score with the same range as the interference score:
0–28. Finally, we calculated a combined interference and
LUTS score by summing the individual interference and
LUTS scores (range: 0–56).
For our analysis of LUTS associated with interference, we
dichotomized LUTS as never versus at least ‘‘rarely’’ and
interference as none versus at least ‘‘a little of the time’’ to
explore the lower ends of the LUTS and interference distri-
butions farthest away from symptomatic urologic disease and
closest to what might represent optimal bladder health. Po-
tential confounding was investigated by comparing propor-
tions of demographic, lifestyle, and clinical variables by
LUTS and interference status. Associations between LUTS
and interference were investigated by calculating crude and
multivariable-adjusted prevalence ratios (PRs), using log-link
generalized linear models with robust variance estimation.
Our first set of multivariable-adjusted models included
terms for age; race/ethnicity; menopausal status; parity;
smoking status; alcohol intake; health-related limitations in
activities; self-reported physician diagnoses of high blood
pressure, types I or II diabetes, cardiovascular disease, and
arthritis; depressive symptoms; and measured BMI and waist
circumference. Our second set included the aforementioned
variables, as well as all individual LUTS, to identify those
independently associated with interference. We also explored
effect modification by age, race/ethnicity, BMI, parity, and
depressive symptoms.
To determine the sensitivity of our findings to our de-
sign/analytic assumptions, we performed several sensitivity
analyses. For our examination of the distribution of blad-
der health, these were: (1) exclusion of women with known
bladder conditions (i.e., current LUTS medications, previous
incontinence or bladder surgery, chronic indwelling cathe-
terization, and bladder cancer), as their exact position on the
LUTS/interference distribution was assumed, not known
based on their untreated LUTS/interference; and women with
nonbladder conditions that might contribute to LUTS or in-
terference (i.e., genitourinary cancers besides bladder cancer,
prolapse of the uterus, bladder, or rectum, congenital uri-
nary tract abnormalities (a large proportion of which are
renal24,25), endometriosis, pelvic inflammatory disease,
chronic pelvic pain, vulvodynia, and diabetes); and (2) ex-
clusion of nocturia and nighttime interference from the list of
LUTS and interference activities, respectively, as these might
be caused by nonbladder-related conditions.
For analyses investigating LUTS associated with inter-
ference, sensitivity analyses were: (1) exclusion of women
with histories of bladder and nonbladder-related conditions
potentially associated with LUTS and/or interference; and
(2) use of higher cutoff points for LUTS (at least ‘‘a few
times’’) and interference (at least ‘‘some of the time’’) to
determine whether associations observed at lower ends of
the spectrum for LUTS and interference were also observed
at higher ends. Analyses were performed using R v3.5.1 and
SAS 9.3.
Results
Of the 3205 female participants who completed the base-
line visit, 36 were excluded due to missing LUTS or inter-
ference data, leaving 3169 participants in the analysis. The
majority of included women were young to middle aged,
White, peri- or postmenopausal, and overweight or obese,
with no health-related limitations in activities (Table 1).
Eighty percent of women reported LUTS at least rarely and
34.5% reported interference at least a little of the time.
Compared with women who did not report LUTS or in-
terference, those who reported any LUTS or interference
were older, and more likely to be peri- or postmenopausal,
have ever smoked cigarettes, be obese or have a large waist
circumference, and report some health-related limitations in
activities or histories of high blood pressure, diabetes types I
and II, cardiovascular disease, and arthritis. Women who
reported LUTS were more likely to be non-Hispanic White,
whereas women who reported interference were more likely
to be non-Hispanic Black, to have had ‡4 pregnancies, and
to have depressive symptoms.
Distribution of LUTS and interference
Overall, 19.9% of women reported never experiencing
LUTS, 15.7% rarely, 23.1% a few times, 15.1% fairly often,
10.0% usually, and 16.3% almost always in the past month
(Table 2). The most commonly reported LUTS were urinat-
ing again after <2 hours, perceived frequency, nocturia, and
urgency. The least common were nonstress, nonurgency in-
continence and UTIs. With respect to interference, 65.5%
reported no interference with any of the seven activities in-
vestigated, 12.9% reported interference a little of the time in
the past month; 8.8% some of the time; 5.6% most of the
INSIGHT INTO BLADDER HEALTH 3
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Table 1. Demographic, Lifestyle, and Clinical Characteristicsa of Women by Frequency of Lower Urinary
Tract Symptoms and Interference with Activities from Urinary Experiences, Pain, or Discomfort
in the Pubic Area in the Past Month; Boston Area Community Health Survey, 2002–2005
Frequency of LUTS Frequency of interference
All participants
(n = 3169)
None
(n = 729)
Ever
(n = 2440) p
None
(n = 2016)
Ever
(n = 1153) p
Age (years, %)
26–44 45.8 54.6 43.6 50.4 37.0
45–64 38.2 29.0 40.5 <0.001 35.6 43.0 <0.001
‡65 16.0 16.4 15.9 13.9 20.1
Race (%)
Black 29.9 34.3 28.8 27.7 34.0
Hispanic 13.2 18.4 11.9 <0.001 13.2 13.3 0.027
White 56.9 47.3 59.2 59.0 52.7
Menopausal status (%)
Premenopausal /Undetermined 34.0 44.1 31.5 39.1 24.4
Perimenopausal 23.3 19.9 24.1 <0.001 22.8 24.2 <0.001
Postmenopausal 24.4 22.7 24.8 23.1 26.8
Surgical 18.3 13.2 19.6 15.0 24.6
Parity (%)b
0 pregnancies 21.2 22.0 21.0 22.9 18.0
1–3 pregnancies 46.7 49.6 46.0 0.336 47.5 45.2 0.027
‡4 pregnancies 32.0 28.2 32.9 29.5 36.6
Cigarette smoking status (%)
Never smoker 50.2 63.3 46.9 52.5 45.8
Former smoker 27.2 19.0 29.2 <0.001 25.6 30.2 0.083
Current smoker 22.6 17.7 23.8 21.9 24.0
Alcohol use (average drinks/day, %)b
<1 drink 28.4 31.6 27.6 27.5 30.0
1–2 drinks 51.6 48.3 52.4 0.411 52.0 50.9 0.639
‡3 drinks 19.9 19.9 19.9 20.3 19.1
BMI (kg/m2, %)b
<25 33.3 38.4 32.1 37.6 25.2
25–29 28.6 30.2 28.2 0.037 29.2 27.5 <0.001
‡30 37.8 31.3 39.4 33.1 46.7
Waist circumference (cm, %)b
<65 3.1 3.9 2.9 3.4 2.5
65–89 51.3 56.9 49.9 0.014 54.3 45.6 0.017
90–114 36.3 34.8 36.6 34.6 39.5
‡115 8.8 4.4 9.9 7.4 11.3
Health-related limitations in activities (%)
Moderate activitiesc
Not limited at all 73.1 83.2 70.5 80.0 59.9
Limited a little 14.9 10.6 16.0 <0.001 12.1 20.3 <0.001
Limited a lot 12.0 6.2 13.5 7.9 19.8
Climbing several flights of stairs
Not limited at all 62.6 77.9 58.8 71.2 46.2
Limited a little 23.1 14.7 25.2 <0.001 19.9 29.2 <0.001
Limited a lot 14.3 7.3 16.0 8.8 24.6
Self-reported physician diagnosis of (%)
High blood pressure 28.2 20.9 30.0 0.001 23.3 37.6 <0.001
Type I diabetes 2.8 1.2 3.1 0.011 1.6 4.9 <0.001
Type II diabetes 7.8 5.0 8.4 0.022 6.1 10.9 0.001
Cardiovascular diseased 19.8 14.6 21.1 0.015 16.1 26.8 <0.001
Arthritis or rheumatism 28.8 18.0 31.5 <0.001 22.9 40.0 <0.001
Depressive symptoms (%)e 20.1 17.1 20.9 0.192 14.9 30.0 <0.001
aAll values were weighted according to the sampling weights of the BACH survey.
bNumbers may not sum to 100% because of missing values.
cExamples for participants included moving a table, pushing a vacuum cleaner, softball, or playing golf.
dIncludes coronary artery bypass, myocardial infarction, arrhythmia, congestive heart failure, transient ischemic attack, stroke, carotid
artery surgery, intermittent claudication, pulmonary embolus, aortic aneurysm, heart rhythm disturbance, Raynaud’s disease, and peripheral
vascular disease.
eDefined as an affirmative response to at least 5 of 8 items on a revised version of the Center for Epidemiologic Studies of Depression Scale.23
BACH, Boston Area Community Health; BMI, body mass index; LUTS, lower urinary tract symptom.
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time; and 7.1% all of the time. In general, women reported a
similar frequency of interference with each of the seven ac-
tivities assessed.
In analyses crossclassifying LUTS and interference,
17.5% of women reported no LUTS or interference, whereas
the remaining 82.5% reported some frequency of LUTS or
interference: 15.1% rare LUTS and/or interference a little of
the time, 21.7% LUTS a few times per month and/or inter-
ference some of the time, 22.6%LUTS fairly often or usually
and/or interference most of the time, and 22.9% LUTS al-
most always and/or interference all of the time, with 4.2%
reporting both (Table 3). A small percentage of women
(5.6%) were classified in the highest category based on their
history of bladder conditions rather than their recent symp-
toms/interference.
Interestingly, within each of these groups, the largest
subgroup was always the group with LUTS but without in-
terference (combined prevalence = 45.2%). Although infor-
mation was not available on all adaptive behaviors for LUTS,
28.2% of women who reported incontinence but not inter-
ference used incontinence protection, possibly implying that
some lack of interference may have been explained by ad-
aptation. Very few women (2.0%) reported interference
without LUTS.
In sensitivity analyses, each of these estimates shifted
slightly more toward no LUTS and no interference when
women with known bladder conditions and nonbladder con-
ditions that might influence LUTS or interference were ex-
cluded (Appendix Table A2). They also shifted slightly more
toward no LUTS and no interference when women with noc-
turia and/or nighttime interference were excluded, and when
younger women were examined (Appendix Table A3).
Considering alternative ways of describing the distribution
of bladder health, a generally similar distribution of LUTS
and interference was obtained when the numbers of LUTS
and activities with interference were used rather than the
maximum frequencies (Fig. 1). A slightly different impres-
sion was obtained when the continuous distributions of LUTS
and interference were plotted, and when a combined con-
tinuous distribution was plotted. In these plots, the percentage
of women with no LUTS or interference remained the same,
but a greater density of values was observed at the lower ends
Table 2. Frequencya of Lower Urinary Tract Symptom and Interference with Activities
from Urinary Experiences, Pain, or Discomfort in the Pubic Area in the Past Month
in a Community-Based Sample of 3169 Women; Boston Area Community Health Survey, 2002–2005
Frequency of LUTS in the past month (%)
None Rarely A few times Fairly often Usually Almost always Ever
Nonstress, nonurgency incontinenceb 91.8 3.7 2.5 1.3 0.3 0.4 8.2
UTIc 90.1 6.6 2.8 0.4 0.1 0.0 9.9
Straining/difficult to begin voiding 89.9 3.6 3.6 1.8 0.4 0.7 10.1
Pain, burning, discomfort in the pubic/
bladder area
88.2 3.6 4.4 1.7 0.9 1.2 11.8
Weak stream 87.3 5.6 3.6 2.0 0.4 1.1 12.7
Urgency incontinenceb 85.2 6.5 5.3 1.6 0.5 0.8 14.7
Dribbling/wet clothes after urination 84.0 5.6 5.9 2.2 1.0 1.3 16.0
Intermittency 84.0 6.8 5.0 1.9 1.1 1.3 16.1
Stress incontinenceb 83.3 6.9 6.9 1.3 0.9 0.7 16.7
Incomplete emptying 73.3 11.8 9.3 2.0 1.4 2.2 26.7
Any incontinenced 69.6 17.4 10.0 1.7 1.3 30.4
Urgency/difficulty postponing urination 66.6 11.7 10.3 5.7 1.9 3.9 33.5
Nocturia 61.1 10.9 13.0 5.2 3.4 6.4 38.9
Perceived frequency 56.7 8.2 11.4 10.0 5.7 8.0 43.3
Urinating again after <2 hours 43.7 12.4 18.7 15.1 4.0 6.2 56.4
Any LUTS 19.9 15.7 23.1 15.1 10.0 16.3 80.2
Activity
Frequency of interference in the past month (%)
None A little Some Most All Ever
Drinking fluids before travel 84.4 7.0 4.3 2.1 2.1 15.6
Driving for 2 hours without stopping 84.0 7.6 4.3 1.8 2.3 16.0
Going to places that may not have a toilet 78.1 9.9 4.4 3.0 4.5 21.9
Playing sports outdoors such as golf 90.3 4.5 2.0 1.1 2.2 9.7
Going to movies, shows, church, etc. 89.9 4.5 2.8 1.5 1.3 10.1
Drinking fluids before bed 81.9 7.7 4.6 3.5 2.3 18.1
Getting enough sleep at night 82.0 6.8 4.7 4.1 2.4 18.0
Interference with any activity 65.5 12.9 8.8 5.6 7.1 34.5
aAll values were weighted according to the sampling weights of the BACH survey.
bAssessed in the past week and categorized into the following frequencies: 0, 1, 2–3, 4–5, 6–7, and ‡8 times.
cAssessed in the past year and categorized into the following frequencies: 0, 1, 2–3, 4–5, 6–7, and ‡8 times.
dAssessed in the past year and categorized into the following groups: none, mild, moderate, severe, and very severe, according to methods
described previously.28
UTI, urinary tract infection.
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of the LUTS and interference distributions, leading to a right-
skewed combined distribution.
LUTS associated with interference
In unadjusted analyses (n= 3117 after excluding women
with missing covariate data), all LUTS were positively asso-
ciated with interference (Table 4). Associations were strongest
for urgency and perceived frequency, and weakest for UTIs.
After adjustment for potential confounders and each individual
LUTS, only a few LUTS remained statistically significantly
associated with interference: urgency incontinence, any in-
continence, urgency, nocturia, perceived frequency, and uri-
nating again after <2 hours.
Most associations tended to be stronger for daytime ac-
tivities and weaker/absent for nighttime activities, whereas
the opposite pattern was observed for nocturia (Appendix
Table A4). Considering all LUTS combined, findings were
strongest for going to movies, shows, and church; playing
sports; going to places without a toilet; and driving without
stopping; and weakest for drinking fluids before travel and
nighttime interference.
Finally, in analyses exploring effect modification, no dis-
tinct patterns were observed for total interference by age,
race/ethnicity, BMI, parity, or depressive symptoms. Gen-
erally similar findings were also observed in sensitivity an-
alyses, except for: (1) attenuated, null findings for urgency
(PR = 1.1, 95% confidence interval [CI] = 0.9–1.4, p = 0.313)
after excluding women with bladder conditions and non-
bladder conditions that might be associated with LUTS an-
d/or interference; and (2) stronger, significant findings for
straining to begin voiding (PR= 1.2, 95% CI = 1.0–1.5, p =
0.020), greatly attenuated, null findings for urgency incon-
tinence (PR = 1.1, 95% CI = 0.9–1.3, p = 0.211), stronger,
significant findings for stress incontinence (PR = 1.2, 95%
CI = 1.0–1.4, p = 0.043), and slightly attenuated nonsignifi-
cant findings for any incontinence (PR = 1.1, 95% CI = 1.0–
1.3, p = 0.150, Appendix Table A5) in analyses using higher
cutoff points for LUTS and interference.
Discussion
In this large representative sample of community-dwelling
women 30–80 years of age, we observed a wide distribution
of LUTS and interference, ranging from no LUTS or inter-
ference (17.5% of women) to LUTS and interference almost
always (22.9%). The remaining 59.6% of women reported
intermediate frequencies of LUTS and/or interference. Ex-
amination of the continuous distributions of LUTS and in-
terference, taking into account both number and frequency of
LUTS and interference, demonstrated clustering at the lower
ends of both distributions and a right-skewed combined dis-
tribution. Storage LUTS, including urgency incontinence,
any incontinence, urgency, nocturia, perceived frequency,
and urinating again after <2 hours, were each independently
associated with interference. Most LUTS associated with
overall interference influenced daytime activities, whereas
nocturia influenced nighttime activities/sleep, as expected.
Joint distribution of LUTS and interference
To our knowledge, only one previous study has evaluated
the relation between LUTS and well-being in community-
dwelling women unselected for LUTS.8 This previous anal-
ysis, conducted in the Epidemiology of LUTS (EpiLUTS)
study, found that 21.3% of women ‡40 years of age reported
no LUTS (using a cutoff point of ‘‘sometimes’’) or perceived
problems with their bladder, 52.1% reported one to two types
of LUTS (storage, voiding, or postmicturition) and/or ‘‘some
very minor’’ to ‘‘moderate’’ problems, and 26.6% reported
all three types of LUTS and/or ‘‘severe’’ to ‘‘many severe’’
problems (all estimates calculated from reference8). Similar
percentages were also obtained when impact rather than
perception of bladder condition was examined: 19.9% re-
ported no LUTS and were ‘‘delighted’’ or ‘‘pleased’’ with
their current urinary symptoms, 51.0% reported one to two
types of LUTS and/or were ‘‘mostly satisfied’’ to ‘‘mostly
dissatisfied’’ with their symptoms, and 29.1% reported three
types of LUTS and/or were ‘‘unhappy’’ or felt ‘‘terribly’’
about their symptoms. These percentages are generally
Table 3. Joint Distributiona of Prevalent Lower Urinary Tract Symptom and Interference with
Activities from Urinary Experiences, Pain, or Discomfort in the Pubic Area in the Past Month
in a Community-Based Sample of 3169 Women; Boston Area Community Health Survey, 2002–2005
Frequency of interferenceb (%)
None of
the time
A little of
the time
Some of
the time
Most of
the time
All of
the time
Frequency of LUTSc No symptoms 17.5 1.2 0.6 0.2 0.0
Rarely 12.6 1.3 0.6 0.0 0.2
A few times 14.1 4.0 2.4 0.6 0.8
Fairly often 7.4 2.6 2.2 1.2 0.7
Usually 4.7 1.4 1.5 0.8 0.9
Almost always 6.4 1.0 1.0 2.1 4.2d/5.6e
aAll values were weighted according to the sampling weights of the BACH survey.
bMaximum frequency of interference across seven activities.
cMaximum frequency of LUTS across 12 LUTS (UTI (in the past year); straining/difficult to begin voiding; pain, burning, discomfort in
the pubic/bladder area; weak stream; dribbling/wet clothes after urination; intermittency; incomplete emptying; any incontinence (in the
past year); urgency/difficulty postponing urination; nocturia; perceived frequency; urinating again after <2 hours).
dRepresents the percentage of women who reported at least one LUTS almost always and interference with at least one activity all the
time in the past month.
eRepresents the percentage of women with self-reported current or past bladder conditions (i.e., use of current LUTS medications,
previous incontinence or bladder surgery, chronic indwelling catheterization, or bladder cancer).
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similar to our estimates of 17.5%, 59.6%, and 22.9%, despite
use of different categorizations of LUTS and measures of
well-being.
Interestingly, the percentages of women who reported
LUTS but only minimal diminished well-being (19.5% ‘‘no
problems’’ and 46.3% ‘‘no’’ or ‘‘some very minor problems’’)
or no LUTS but some degree of diminished well-being
(4.0% and 0.0% using the same thresholds) were also sim-
ilar to our estimates of 45.2% and 2.0%, depending on the
threshold used. Similar estimates were also obtained when
impact rather than perception of bladder condition was ex-
amined, but only when a considerably higher threshold of
impact was used (54.6% reported LUTS but a ‘‘delighted’’
through ‘‘mixed’’ view of their urinary symptoms, and 0.0%
reported no LUTS but a ‘‘mostly dissatisfied’’ through
‘‘terrible’’ view of their urinary symptoms), possibly im-
plying differences in how participants rate impact and per-
ceived bladder condition.
Together with our findings, these results suggest that ap-
proximately one in five women (18%–21%) over 30 years of
age would be considered to have optimal bladder health
based on their lack of both LUTS and interference/impact;
the majority (51%–60%) would be considered to have good
or intermediate health based on their intermediate frequency
or number of LUTS and interference/impact; and approxi-
mately one in four (23%–29%) would be considered to have
FIG. 1. Joint distributiona of prevalent LUTS and interference with activities from urinary experiences, pain, or dis-
comfort in the pubic area in the past month in a community-based sample of 3169 women; BACH survey, 2002–2005. aAll
values were weighted according to the sampling weights of the BACH survey. bIncludes 12 LUTS (UTI (in the past year);
straining/difficult to begin voiding; pain, burning, discomfort in the pubic/bladder area; weak stream; dribbling/wet clothes
after urination; intermittency; incomplete emptying; any incontinence (in the past year); urgency/difficulty postponing
urination; nocturia; perceived frequency; urinating again after <2 hours). cRepresents the percentage of women who
reported 8–12 LUTS at least rarely and interference at least a little of the time with 4–7 activities in the past month.
dRepresents the percentage of women with self-reported current or past bladder conditions (i.e., use of current LUTS
medications, previous incontinence or bladder surgery, chronic indwelling catheterization, or bladder cancer). eCalculated
by summing the frequency of interference (0–4) with each of the seven activities (range: 0–28). fCalculated by summing the
frequency (0–5, except for incontinence in the past year = 0–4) of 12 LUTS (range: 0–59) and then multiplying by 28/59 to
obtain the same range as the interference score (range: 0–28). gCalculated as the sum of the LUTS and interference scores
(range: 0–56). BACH, Boston Area Community Health; LUTS, lower urinary tract symptom.
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worse or poor bladder health based on their maximum fre-
quency/number of LUTS and interference/impact.
Consistent with our working bladder health definition,
these estimates take into consideration both LUTS and LUTS-
related well-being, but refer only to women’s current (rather
than future or past) state. However, if we expanded our defi-
nition to consider other factors, such as known risk factors for
future LUTS development, our inferences might change. For
instance, in the heart disease field, ‘‘ideal’’ cardiovascular
health (estimated to occur in only 5% of the U.S. population)
is defined as the absence of cardiovascular disease, and the
simultaneous presence of several favorable health behaviors
and factors, such as not smoking, and having a normal BMI
and low, untreated cholesterol and blood pressure.26
Although some risk factors have been identified for urinary
incontinence (e.g., obesity and parity27), health factors or
biologic mediators analogous to high cholesterol and blood
pressure have not yet been identified for LUTS, and thus
could not be incorporated into our definition of bladder
health. On the other hand, our definition includes well-being,
which is not included explicitly in the current cardiovascular
health definition, but incorporated conceptually through its
associations with health behaviors/factors. Clearly, many
ways exist to define and quantify health, and we anticipate
future modifications to our definition as we learn more about
this concept.
In addition to larger theoretical considerations for defining
bladder health, our estimates are approximate for several
reasons. First, they may over-estimate categories of better
bladder health because of: (1) lack of information about in-
terference with activities more common in women, younger
individuals, or those with incontinence (e.g., interference
with occupational activities, childcare activities, household
chores, sexual activities, choice of clothing, laughing, and
indoor sports and exercise), as the Epstein scale was designed
for and validated in older men with BPH19; and (2) minimal
information on adaptation or coping strategies for LUTS
beyond incontinence protection (e.g., reduced fluid intake,
normalization of LUTS with aging), which may have limited
their perceived interference.
Lack of information about LUTS beyond the 15 assessed
in BACH is unlikely to have overinflated our estimates of
better bladder health because only a very small percentage of
women reported interference without LUTS, implying few
unassessed LUTS.
With respect to under- rather than overestimation of better
bladder health, inclusion of LUTS or interference from
nonbladder-related conditions is unlikely to have under-
estimated better bladder health because these numbers were
changed only minimally when women with nonbladder-
related conditions were excluded from the analyses. Finally,
use of a different measure of LUTS-related well-being, as
Table 4. Associations Between Prevalent Lower Urinary Tract Symptom and Interference
with Activities from Urinary Experiences, Pain, or Discomfort in the Pubic Area in the Past Month
in a Community-Based Sample of 3117 Women; Boston Area Community Health Survey, 2002–2005
LUTS (at least rarely
in the past month)
Prevalence of
interference
at least a little
of the time (%a) PR of interference at least a little of the time (95% CI)
No LUTS LUTS Unadjusted Adjustedb p Adjustedc p
Nonstress, nonurgency incontinenced 30.7 73.3 2.4 (2.1–2.8) 1.7 (1.4–2.0) <0.001 1.1 (0.9–1.2) 0.266
UTIe 32.8 46.7 1.4 (1.2–1.7) 1.3 (1.1–1.5) 0.013 1.0 (0.9–1.2) 0.635
Straining/difficult to begin voiding 30.8 64.4 2.1 (1.8–2.5) 1.6 (1.4–1.9) <0.001 1.1 (0.9–1.2) 0.451
Pain, burning, discomfort in the pubic/
bladder area
29.4 69.8 2.4 (2.1–2.7) 1.8 (1.5–2.1) <0.001 1.1 (1.0–1.3) 0.087
Weak stream 29.6 66.9 2.3 (2.0–2.6) 1.8 (1.6–2.1) <0.001 1.1 (0.9–1.2) 0.353
Urgency incontinenced 28.0 70.9 2.5 (2.2–2.9) 1.9 (1.7–2.2) <0.001 1.2 (1.1–1.4) 0.001
Dribbling/wet clothes after urination 27.9 66.9 2.4 (2.1–2.7) 1.9 (1.7–2.2) <0.001 1.1 (1.0–1.2) 0.170
Intermittency 29.5 58.5 2.0 (1.7–2.3) 1.6 (1.4–1.8) <0.001 1.0 (0.8–1.1) 0.590
Stress incontinenced 29.3 58.8 2.0 (1.7–2.3) 1.6 (1.4–1.8) <0.001 1.1 (1.0–1.2) 0.232
Incomplete emptying 26.4 55.2 2.1 (1.8–2.4) 1.7 (1.5–2.0) <0.001 1.1 (1.0–1.3) 0.108
Any incontinencee 25.7 53.8 2.1 (1.8–2.4) 1.7 (1.5–2.0) <0.001 1.2 (1.1–1.4) 0.002
Urgency/difficulty postponing urination 22.0 58.8 2.7 (2.3–3.1) 2.3 (1.9–2.6) <0.001 1.3 (1.1–1.6) 0.001
Nocturia 21.8 53.5 2.5 (2.0–2.9) 2.0 (1.7–2.4) <0.001 1.3 (1.1–1.5) 0.004
Perceived frequency 20.0 52.8 2.6 (2.2–3.1) 2.3 (2.0–2.7) <0.001 1.5 (1.2–1.7) <0.001
Urinating again after <2 hours 19.1 45.7 2.4 (2.0–2.9) 2.2 (1.9–2.6) <0.001 1.3 (1.1–1.5) 0.004
Any LUTS 10.7 40.0 3.7 (2.6–5.4) 3.5 (2.4–5.0) <0.001 — —
aAll values were weighted according to the sampling weights of the BACH survey.
bAdjusted for age (26–44, 45–64, or ‡65 years); race/ethnicity (Black, Hispanic, orWhite); menopausal status (premenopausal /undetermined,
perimenopausal, postmenopausal, or surgical); parity (0, 1–3, or ‡4 pregnancies); smoking status (current, former, or never smoker); alcohol
intake (<1, 1–2, or ‡3 drinks); BMI (<25, 25–29, or‡30kg/m2); waist circumference (<65, 65–89, 90–114, or ‡115 cm); health-related limitations
in activities (not at all, a little, or a lot); self-reported physician diagnoses of high blood pressure, types I or II diabetes, cardiovascular disease, and
arthritis; and depressive symptoms (yes or no).
cAdditionally adjusted for other LUTS individually, as appropriate.
dAssessed in the past week.
eAssessed in the past year.
CI, confidence interval; PR, prevalence ratio.
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well as incorporation of a measure of bladder resilience (i.e.,
the ability to adapt to short-term physical and environmental
stressors) might further influence our estimates of bladder
health. Nonetheless, given the overall similarity between our
estimates and those from the EpiLUTS study, an unrelated
study with different categories of LUTS and measures of
well-being, we do not expect the above-described consider-
ations to affect our overall conclusion about bladder health
notably.
LUTS associated with interference
Similar to our bladder health distribution findings, our
findings for LUTS associated with interference were gener-
ally consistent with those from the previous EpiLUTS anal-
ysis.8 That study found that bother from a number of storage
symptoms, including frequency, nocturia, urgency, and all
forms of incontinence were independently associated with at
least ‘‘moderate’’ perceived problems, similar to our findings
for urinating again after <2 hours, perceived frequency,
nocturia, urgency, urgency incontinence, and any inconti-
nence. The EpiLUTS Study also found that incomplete
emptying was associated with perceived problems, whereas
we found only suggestive positive findings for this LUTS.
Altogether, these findings suggest that LUTS that are difficult
to defer (i.e., frequent or urgent urination) contribute to
greater diminished well-being, whereas those related to
voiding once initiated may be less impactful on daily activ-
ities and optimal well-being.
Conclusions
In this large representative sample of community-dwelling
women unselected for LUTS, we found that bladder health
exists on a continuum, with approximately one in five women
considered to have optimal bladder health (no LUTS or inter-
ference), three in five good to intermediate health (intermediate
frequency of LUTS or interference), and one in five worse or
poor health (LUTS or interference all the time). We also found
that storage LUTS were associated with interference.
Altogether, these findings provide useful preliminary es-
timates for conceptualizing and quantifying the spectrum of
bladder health, and for understanding the LUTS that interfere
with women’s lives. Ongoing and future PLUS studies will
complement and extend these findings by exploring bladder
health and ‘‘normal’’ bladder function from women’s per-
spectives; developing measures to capture these new and
evolving concepts, including new measures of resilience and
well-being appropriate for all LUTS; and, ultimately, iden-
tifying and intervening upon factors that promote lifelong
bladder health.12 The importance of this last goal is under-
scored by the small percentage of women found to have
‘‘optimal’’ bladder health in our analysis.
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Appendix Table A1. Lower Urinary Tract Symptoms Assessed in the Boston
Area Community Health Survey, 2002–2005
Items collected in the BACH survey Collapsed items
Number of times you accidentally leaked urine without any particular
physical activity or warning in the past 7 days
Nonstress, nonurgency incontinence
in the past week
Number of bladder infections in the past yeara UTI in the past year
Number of kidney infections in the past yeara
Push or strain to begin urination in the past monthb Straining/difficult to begin voiding
in the past monthDifficulty starting to urinate in the past monthb
Pain or burning during urination in the past monthc Pain, burning, discomfort in the pubic/
bladder area in the past monthPain, burning, discomfort, or pressure in your pubic or bladder area
in the past monthc
Pain or discomfort in your urethra in the past monthc
Pain increasing when your bladder fills in the past monthc
Pain relieved by urination in the past monthc
Weak urinary stream in the past month Weak stream in the past month
Number of times you accidentally leaked urine when you had the
strong feeling that you needed to empty your bladder but you
could not get to the toilet fast enough in the past 7 days
Urgency incontinence in the past week
Dribbling after urination in the past monthd Dribbling/wet clothes after urination
in the past monthWet clothes because of dribbling after urination in the past monthd
Stop and start again several times while you urinate in the past month Intermittency in the past month
Number of times you accidentally leaked urine when you were
performing some physical activity, such as coughing, sneezing,
lifting, or exercise, in the past 7 days
Stress incontinence in the past week
Sensation of not emptying your bladder completely after you have
finished urinating in the past month
Incomplete emptying in the past month
Leaked even a small amount of urine in the past 12 months,
including frequency and amount
Any incontinence in the past year
Difficulty postponing urination in the past monthe Urgency/difficulty postponing urination
in the past monthStrong urge or pressure to urinate immediately, with no, or little warning
in the past monthe
Get up to urinate more than once during the night in the past month Nocturia in the past month
Frequent urination during the day in the past monthf Perceived frequency in the past month
Urinate again less than 2 hours after you finished
urinating in the past monthf
Urinating again after <2 hours (frequency)
in the past month
Strong urge or pressure that signaled the need to urinate immediately,
whether or not you urinated or leaked urine in the past 7 days
g
a% Disagreement (comparing those without a particular LUTS to those who reported experiencing it at least rarely)= 8.6%.
b% Disagreement = 6.6%.
c% Disagreement = 4.8%–8.6%.
d% Disagreement = 6.3%.
e% Disagreement = 20.2%.
f% Disagreement = 25.5%.
gNot included in the analysis.
BACH, Boston Area Community Health; LUTS, lower urinary tract symptom; UTI, urinary tract infection.
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Appendix Table A2. Joint Distributiona of Prevalent Lower Urinary Tract Symptom and Interference
with Activities from Urinary Experiences, Pain, or Discomfort in the Pubic Area in the Past Month
in Select Populations of Women; Boston Area Community Health Survey, 2002–2005
Excluding women with known bladder conditionsb and nonbladder conditions that might influence LUTS and/or interferencec
Frequency of interferenced (%)
None of
the time
A little of
the time
Some of
the time
Most of
the time
All of
the time
Frequency of LUTSe No symptoms 22.6 1.3 0.3 0.4 0.1
Rarely 15.7 1.3 0.4 0.0 0.2
A few times 14.1 4.3 2.2 0.6 0.7
Fairly often 7.6 2.7 2.9 0.9 0.8
Usually 4.9 1.1 1.8 0.5 0.4
Almost always 6.4 1.4 0.9 1.4 2.3
Excluding nocturia and nighttime interferencef
Frequency of interferenced (%)
None of
the time
A little of
the time
Some of
the time
Most of
the time
All of
the time
Frequency of LUTSe No symptoms 21.2 1.3 0.4 0.1 0.1
Rarely 13.2 1.0 0.6 0.0 0.2
A few times 14.8 3.7 1.5 0.2 0.5
Fairly often 9.5 2.2 2.3 0.7 0.6
Usually 4.0 1.4 1.2 0.5 0.7
Almost always 5.8 0.9 0.7 1.6 3.4g/5.8h
aAll values were weighted according to the sampling weights of the BACH survey.
bCurrent LUTS medication use, previous incontinence or bladder surgery, chronic indwelling catheterization, or bladder cancer.
cGenitourinary cancers besides bladder cancer, prolapse of the uterus, bladder, or rectum, congenital urinary tract abnormalities (which
are mainly renal), endometriosis, pelvic inflammatory disease, chronic pelvic pain, vulvodynia, and diabetes.
dMaximum frequency of interference across seven activities.
eMaximum frequency of LUTS across 12 LUTS (UTI [in the past year]); straining/difficult to begin voiding; pain, burning, discomfort in
the pubic/bladder area; weak stream; dribbling/wet clothes after urination; intermittency; incomplete emptying; any incontinence (in the
past year); urgency/difficulty postponing urination; nocturia; perceived frequency; urinating again after <2 hours).
fDrinking fluids before bed and getting enough sleep at night.
gRepresents the percentage of women who reported at least one LUTS almost always and interference with at least one activity all the
time in the past month.
hRepresents the percentage of women with self-reported current or past bladder conditions (i.e., use of current LUTS medications,
previous incontinence or bladder surgery, chronic indwelling catheterization, or bladder cancer).
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Appendix Table A3. Joint Distributiona of Prevalent Lower Urinary Tract Symptom and Interference
with Activities from Urinary Experiences, Pain, or Discomfort in the Pubic Area in the Past Month
in Women by Age Group; Boston Area Community Health Survey, 2002–2005
26–44 years of age
Frequency of interferenceb (%)
None of
the time
A little of
the time
Some of
the time
Most of
the time
All of
the time
Frequency of LUTSc No symptoms 21.2 1.2 0.8 0.2 0.0
Rarely 13.5 1.5 0.7 0.0 0.0
A few times 14.5 3.2 1.8 1.0 0.3
Fairly often 8.4 3.2 2.0 0.7 0.3
Usually 5.0 1.8 1.5 0.7 0.9
Almost always 7.3 0.7 0.8 1.3 2.2d/3.3e
45–64 years of age
Frequency of interferenceb (%)
None of
the time
A little of
the time
Some of
the time
Most of
the time
All of
the time
Frequency of LUTSc No symptoms 13.6 0.9 0.2 0.1 0.1
Rarely 12.8 1.3 0.3 0.0 0.6
A few times 14.5 4.6 2.8 0.3 0.9
Fairly often 6.4 2.6 1.9 1.2 1.3
Usually 4.4 1.3 1.9 0.7 1.2
Almost always 5.9 0.9 1.4 3.2 6.7d/6.2e
45–64 years of age
Frequency of interferenceb (%)
None of
the time
A little of
the time
Some of
the time
Most of
the time
All of
the time
Frequency of LUTSc No symptoms 16.3 2.1 1.0 0.8 0.0
Rarely 9.5 0.7 0.6 0.0 0.0
A few times 12.0 5.1 3.2 0.4 1.6
Fairly often 6.9 1.3 3.6 2.8 0.5
Usually 4.1 0.7 0.7 1.2 0.5
Almost always 4.9 2.0 0.8 1.9 4.4d/10.4e
aAll values were weighted according to the sampling weights of the BACH survey.
bMaximum frequency of interference across seven activities.
cMaximum frequency of LUTS across 12 LUTS (UTI (in the past year); straining/difficult to begin voiding; pain, burning, discomfort in
the pubic/bladder area; weak stream; dribbling/wet clothes after urination; intermittency; incomplete emptying; any incontinence (in the
past year); urgency/difficulty postponing urination; nocturia; perceived frequency; urinating again after <2 hours).
dRepresents the percentage of women who reported at least one LUTS almost always and interference with at least one activity all the
time in the past month.
eRepresents the percentage of women with self-reported current or past bladder conditions (i.e., use of current LUTS medications,
previous incontinence or bladder surgery, chronic indwelling catheterization, or bladder cancer).
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Appendix Table A4. Multivariable-Adjusted Associations (Prevalence Ratios)a Between
Prevalent Lower Urinary Tract Symptom and Interference with Activities from Urinary
Experiences, Pain, or Discomfort in the Pubic Area in the Past Month in Women;
Boston Area Community Health Survey, 2002–2005
LUTS (at least rarely
in the past month)
Any
interference
(at least
a little of
the time)
Daytime activities Nighttime activities
Drinking
fluids
before
travel
Driving
2 hours
without
stopping
Going to
places that
may not
have a toilet
Playing
sports
Going to
movies,
shows,
church, etc
Drinking
fluids
before
bed
Getting
enough
sleep at
night
Nonurgency, nonstress
incontinenceb
1.1 1.1 1.2 1.1 1.8** 2.0** 1.3** 1.4**
UTIc 1.0 1.1 1.0 0.9 0.8 0.9 0.9 1.0
Straining/difficult to begin voiding 1.1 1.3** 1.5** 1.1 1.6** 1.2 1.2** 1.1
Pain, burning, discomfort
in the pubic/bladder area
1.1* 1.0 1.2 1.1 0.9 0.9 1.1 1.1
Weak stream 1.1 1.0 1.0 1.1 1.2 1.0 1.2 1.1
Urgency incontinenceb 1.2** 1.5** 1.3** 1.3** 2.2** 2.2** 1.2 1.1
Dribbling/wet clothes after
urination
1.1 1.2 1.2 1.2 1.4* 1.4** 1.4** 1.2**
Intermittency 1.0 1.0 1.2 1.0 0.8 0.8* 0.9 0.9
Stress incontinenceb 1.1 1.5** 1.4** 1.3** 2.3** 1.9** 1.3** 1.3**
Incomplete emptying 1.1 1.2 1.3** 1.1 1.4* 1.2 1.1 1.0
Any incontinencec 1.2** 1.4** 1.3** 1.3** 2.4** 2.0** 1.2 1.2*
Urgency/difficulty postponing
urination
1.3** 1.9** 1.4** 1.6** 1.3 3.2** 1.4** 1.6**
Nocturia 1.3** 1.1 1.0 1.1 0.8 1.0 1.6** 2.9**
Perceived frequency 1.5** 1.8** 2.1** 1.7** 2.1** 1.0 1.2 1.3*
Urinating again after <2 hours 1.3** 1.0 1.2 1.4** 1.4 1.3 1.3 1.3*
Any LUTS 3.5** 3.7** 6.5** 8.3** 16.3** 22** 4.1** 5.2**
*0.1 < p£ 0.05; **p < 0.05.
aAdjusted for age (26–44, 45–64, or ‡65 years); race/ethnicity (Black, Hispanic, or White); menopausal status (premenopausal /
undetermined, perimenopausal, postmenopausal, or surgical); parity (0, 1–3, or ‡4 pregnancies); smoking status (current, former, or never
smoker); alcohol intake (<1, 1–2, or ‡3 drinks); BMI (<25, 25–29, or ‡30 kg/m2); waist circumference (<65, 65–89, 90–114, or ‡115 cm);
health-related limitations in activities (not at all, a little, or a lot); self-reported physician diagnoses of high blood pressure, types I or II
diabetes, cardiovascular disease, and arthritis; depressive symptoms (yes or no), and other LUTS individually, as appropriate.
bAssessed in the past week.
cAssessed in the past year.
BMI, body mass index.
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Appendix Table A5. Associations Between Prevalent Lower Urinary Tract Symptom and Interference
with Activities from Urinary Experiences, Pain, or Discomfort in the Pubic Area in the Past Month
in Women; Boston Area Community Health Survey, 2002–2005
LUTS (at least a few times
in the past month)
Prevalence of
interference at
least some of
the time (%a) PR of interference at least some of the time (95% CI)
No LUTS LUTS Unadjusted Adjustedb p Adjusted c p
Nonstress, nonurgency incontinenced 18.1 57.6 3.2 (2.6–3.9) 2.0 (1.6–2.5) <0.001 1.0 (0.8–1.2) 0.806
UTIe 20.4 29.1 1.4 (1.0–1.9) 1.3 (1.0–1.6) 0.042 0.9 (0.7–1.1) 0.195
Straining/difficult to begin voiding 18.5 62.0 3.4 (2.7–4.2) 2.1 (1.7–2.6) <0.001 1.2 (1.0–1.5) 0.020
Pain, burning, discomfort in the pubic/
bladder area
18.2 55.8 3.1 (2.4–3.9) 2.0 (1.6–2.4) <0.001 1.1 (0.9–1.3) 0.361
Weak stream 18.3 61.6 3.4 (2.7–4.2) 2.3 (1.9–2.8) <0.001 1.1 (0.9–1.3) 0.379
Urgency incontinenced 16.5 49.6 3.0 (2.5–3.7) 2.2 (1.8–2.6) <0.001 1.1 (0.9–1.3) 0.211
Dribbling/wet clothes after urination 17.4 54.3 3.1 (2.5–3.9) 2.2 (1.8–2.7) <0.001 1.0 (0.8–1.2) 0.912
Intermittency 18.1 52.1 2.9 (2.3–3.5) 1.9 (1.6–2.3) <0.001 1.1 (0.9–1.3) 0.372
Stress incontinenced 16.9 43.4 2.6 (2.0–3.2) 1.9 (1.6–2.3) <0.001 1.2 (1.0–1.4) 0.043
Incomplete emptying 17.2 44.3 2.6 (2.1–3.1) 1.9 (1.6–2.2) <0.001 1.0 (0.9–1.2) 0.589
Any incontinencee 16.6 52.0 3.1 (2.6–3.8) 2.1 (1.8–2.6) <0.001 1.1 (1.0–1.3) 0.150
Urgency/difficulty postponing urination 12.5 53.4 4.3 (3.4–5.3) 3.3 (2.6–4.1) <0.001 1.7 (1.4–2.2) <0.001
Nocturia 11.8 45.7 3.9 (3.1–4.8) 3.0 (2.5–3.7) <0.001 1.8 (1.5–2.2) <0.001
Perceived frequency 12.4 37.6 3.0 (2.4–3.8) 2.5 (2.0–3.1) <0.001 1.3 (1.1–1.5) 0.005
Urinating again after <2 hours 11.4 33.7 3.0 (2.3–3.7) 2.6 (2.1–3.2) <0.001 1.3 (1.0–1.6) 0.026
Any LUTS 5.1 28.9 5.6 (3.7–8.6) 5.2 (3.5–7.8) <0.001 — —
aAll values were weighted according to the sampling weights of the BACH survey.
bAdjusted for age (26–44, 45–64, or ‡65 years); race/ethnicity (Black, Hispanic, orWhite); menopausal status (premenopausal /undetermined,
perimenopausal, postmenopausal, or surgical); parity (0, 1–3, or ‡4 pregnancies); smoking status (current, former, or never smoker); alcohol
intake (<1, 1–2, or‡3 drinks); BMI (<25, 25–29, or ‡30 kg/m2);waist circumference (<65, 65–89, 90–114, or ‡115 cm); health-related limitations
in activities (not at all, a little, or a lot); self-reported physician diagnoses of high blood pressure, types I or II diabetes, cardiovascular disease, and
arthritis; and depressive symptoms (yes or no).
cAdditionally adjusted for other LUTS individually, as appropriate.
dAssessed in the past week.
eAssessed in the past year.
CI, confidence interval; PR, prevalence ratio.
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